Medicinal Cannabis: The Evidence’, a comprehensive and up to date review of the evidence supporting the use of cannabis as medicine, was just published by CLEAR.

Th report details an extraordinary quantity of peer-reviewed, published evidence that demonstrates the efficacy and safety of using cannabis to treat a wide range of conditions.  It looks in detail at five therapeutic areas where the evidence is strongest: Alzheimer’s Disease, Cancer, Chronic Pain, Crohn’s Disease and Multiple Sclerosis.

Archaeological and written evidence suggests mankind has used cannabis for medicinal purposes for as long as 10,000 years.  In the 19th century nearly half of all medicines in the British and US pharmacopeia contained cannabis. With the rise of new pharmaceutical medicines it fell into disuse but in 1996 California introduced the first ‘medical marijuana’ laws.  Now 210 million people in 34 US states and 250 million people in nine European countries have some form of legal access.

Peter Reynolds, author of the report, said:

“This review finally does away with the myth that there is no proof of the value of medicinal cannabis.  There is high quality evidence available from dozens of different sources, including double-blind, placebo-controlled clinical trials.  No one who examines the evidence can be in any doubt, any longer.  This is a medicine that saves lives and rescues people from pain, suffering and disability with far fewer dangerous and unpleasant side effects than pharmaceutical products.  We must move urgently to allow doctors to start prescribing and introduce professional training in the use of cannabis medicines”

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert